Early-stage glottic SCC carries a favorable prognosis with low rates of long-term complications when treated with RT. One particular advantage to using RT is improved preservation of voice quality compared to laryngectomy. Historically, small, daily fractions were used to treat these lesions; however, treatment has evolved to a more hypofractionated, shorter overall treatment course without sacrificing LC or increasing complications. This chapter summarizes the use of hypofractionated RT for the treatment of early-stage SCC of the glottic larynx.
KeywordsLaryngeal carcinoma Radiation therapy Hypofractionation
- 1.Garden AS, Beadle BM, Morrison WH. Larynx and hypopharynx cancer. Clinical radiation oncology. 4th ed. Philadelphia, PA: Saunders/Elsevier. p. 649–72.Google Scholar
- 2.Treatment of early (stage I and II) head and neck cancer: The larynx. Accessed 22 July 2016.Google Scholar
- 3.Moon SH, Cho KH, Chung EJ, et al. A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean radiation oncology group (KROG-0201) study. Radiother Oncol. 2014;110:98–103.CrossRefPubMedGoogle Scholar